Scarica l'app Stockscreener
76.97
1.45%
1.10
Dopo l'orario di chiusura:
69.98
-6.99
-9.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Incyte Corp Borsa (INCY) Ultime notizie
Seizert Capital Partners LLC Has $6.24 Million Position in Incyte Co. (NASDAQ:INCY) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 49,495 Shares of Incyte Co. (NASDAQ:INCY) - MarketBeat
Here’s How Jakafi’s Patent Expiry Impacts Incyte Corporation’s (INCY) Growth Prospects - Insider Monkey
Incyte Co. (NASDAQ:INCY) Shares Purchased by Mizuho Securities USA LLC - MarketBeat
Incyte Co. (NASDAQ:INCY) Shares Sold by Principal Financial Group Inc. - MarketBeat
Incyte Corp. stock outperforms competitors despite losses on the day - MarketWatch
KBC Group NV Reduces Position in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte's SWOT analysis: stock faces patent cliff as pipeline progresses By Investing.com - Investing.com Australia
Incyte to Present at Upcoming Investor Conference - Yahoo Finance
INCY (Incyte) Cash Flow from Operations : $102 Mil (TTM As of Sep. 2024) - GuruFocus.com
Incyte's SWOT analysis: stock faces patent cliff as pipeline progresses - Investing.com
Anal Cancer Market Revenue to Expand Significantly by 2034, States DelveInsight Report | Incyte Corp, BioMimetix, Inovio Pharma, Merck Sharp & Dohme, Dustin Deming, Advaxis - The Globe and Mail
Anal Cancer Market Revenue to Expand Significantly by 2034, - openPR
State of New Jersey Common Pension Fund D Reduces Stock Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Co. (NASDAQ:INCY) Shares Sold by Amalgamated Bank - MarketBeat
Los Angeles Capital Management LLC Lowers Stock Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat
Chronic Hand Eczema Pipeline Update 2024: FDA Approvals, - openPR
Applied Finance Capital Management LLC Reduces Stock Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Barry P. Flannelly Sells 3,680 Shares of Incyte Co. (NASDAQ:INCY) Stock - MarketBeat
Incyte Insider Sold Shares Worth $293,210, According to a Recent SEC Filing - Marketscreener.com
Incyte Co. (NASDAQ:INCY) Stock Holdings Lowered by ARK Investment Management LLC - MarketBeat
Incyte Corp. stock outperforms competitors on strong trading day - MarketWatch
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Van ECK Associates Corp Has $8.79 Million Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat
Greenwood Capital Associates LLC Acquires Shares of 6,546 Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Corporation: Will Their Focus on Oncological Innovations Pay Off?Major Drivers - Smartkarma
Incyte stock soars to 52-week high, hits $76.58 - Investing.com
Robeco Institutional Asset Management B.V. Buys 70,596 Shares of Incyte Co. (NASDAQ:INCY) - MarketBeat
NJ Judge Blocks Sun Pharma From Launching Hair Loss Drug - Law360
Incyte (NASDAQ:INCY) Sets New 52-Week HighWhat's Next? - MarketBeat
Incyte Corp (INCY)'s Winning Formula: Financial Metrics and Comp - GuruFocus.com
Incyte Co. (NASDAQ:INCY) Stock Holdings Trimmed by State of Alaska Department of Revenue - MarketBeat
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday - MSN
Incyte (NASDAQ:INCY) Posts Quarterly Earnings Results, Misses Expectations By $0.12 EPS - MarketBeat
INCY Q3 Earnings Miss Estimates, Revenues Beat on Higher Product Sales - MSN
Incyte Corporation (NASDAQ:INCY) Q3 2024 Earnings Call Transcript - Insider Monkey
14,631 Shares in Incyte Co. (NASDAQ:INCY) Acquired by Integrated Advisors Network LLC - MarketBeat
Incyte Corp (INCY) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com
Earnings call: Incyte reports robust growth and pipeline progress - Investing.com
Incyte's Jakafi Demand Is Strong, Analyst Upgrades Stock - Yahoo Finance
Incyte Raises Jakafi Sales Forecast, Surpassing Expectations - Finimize
Incyte (NASDAQ:INCY) Price Target Raised to $71.00 - MarketBeat
Incyte shares target upgraded, outperform rating on strong Q3 sales - Investing.com
Incyte stock target raised, underperform rating held on Jakafi revenue outlook - Investing.com
Incyte shares target raised, rating held on strong 3Q results - Investing.com
Incyte to Present at Upcoming Investor Conferences - Yahoo Finance
Incyte Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Incyte stock sees upside with strong Jakafi performance and robust pipeline—Citi - Investing.com
Incyte (INCY) PT Raised to $87 at Leerink Partners - StreetInsider.com
Incyte (INCY) PT Raised to $97 at Citi - StreetInsider.com
Incyte Co. (NASDAQ:INCY) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Incyte Corp (INCY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Incyte: Q3 Earnings Snapshot - The Pioneer
Incyte Corp (INCY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Jefferies lifts Incyte target to $84, maintains buy on Q3 beat - Investing.com
Incyte (INCY) PT Raised to $84 at Jefferies - StreetInsider.com
7.22%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):